The Patent Finder

Terms ending in 2035

Kymab Limited

Every in-force patent on Kymab Limited's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,259,880Anti-Light Antibodies
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,512,229Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,587,030Anti-hOX40L Antibodies, Uses, & Methods
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,868,789Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,868,790Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 10,654,935Methods of Treating Sle with ANTI-OX40L Antibodies
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 10,669,342ANTI-OX40L Antibodies and Methods of Treating Graft Versus Host Disease
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 11,396,550Methods of Treating Comprising Administering ANTI-OX40L Antibodies
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 11,753,479Nucleic Acids Encoding ANTI-OX40L Antibodies
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 11,773,175Antibodies, Uses & Methods
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
3 more term ends in 2035 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited